Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
about
Human Th1 cells that express CD300a are polyfunctional and after stimulation up-regulate the T-box transcription factor eomesoderminEffects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and UveitisDifferential expression of CD300a/c on human TH1 and TH17 cellsControl of T(H)17/T(reg) balance by hypoxia-inducible factor 1Fate mapping of IL-17-producing T cells in inflammatory responsesA look at autoimmunity and inflammation in the eyeInvolvement of B cells in non-infectious uveitisToll-Like Receptors in the Pathogenesis of Autoimmune DiseasesAutoimmune valvular carditisDefining the functional states of Th17 cellsNK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis.Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitisNuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signallingDietary Omega-3 Fatty Acids Suppress Experimental Autoimmune Uveitis in Association with Inhibition of Th1 and Th17 Cell FunctionRoles of interleukin-17 in uveitisMesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsEnvironmental microbes and uveitis: is microbial exposure always bad?Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitisIdentification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosisEffects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in miceMethylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitisECM1 controls T(H)2 cell egress from lymph nodes through re-expression of S1P(1)Comparative transcriptomics of Atlantic Salmo salar, chum Oncorhynchus keta and pink salmon O. gorbuscha during infections with salmon lice Lepeophtheirus salmonisIK acts as an immunoregulator of inflammatory arthritis by suppressing TH17 cell differentiation and macrophage activationInflammatory bowel diseaseMHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.Location of CD4+ T cell priming regulates the differentiation of Th1 and Th17 cells and their contribution to arthritis.Administration of Mycobacterium leprae rHsp65 aggravates experimental autoimmune uveitis in mice.Autoimmune T cell responses in the central nervous systemMinireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.SLAT/Def6 plays a critical role in the development of Th17 cell-mediated experimental autoimmune encephalomyelitis.CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell functionSOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile.Th17 and Th1 T-cell responses in giant cell arteritis.MeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5.IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis.Antigen-specific CD25- Foxp3- IFN-gamma(high) CD4+ T cells restrain the development of experimental allergic encephalomyelitis by suppressing Th17.Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
P2860
Q21091134-4229BB13-6214-4BB9-B3B9-70A41C56C9A0Q22299388-6EDA9642-089E-4C99-BD9A-165317A9D63AQ24295286-E2B42459-28DC-4092-AE36-AD0E9044336BQ24336199-5FE0A5E6-7FCC-433A-AAFB-54CB46EB0746Q24621244-2DA36350-4270-4255-A50E-76471B4D2883Q24623065-C27FA911-44A0-49A8-9BE0-2156CDA5243AQ26766611-C925C1E8-FEE0-41C8-B4BE-909AEF0969A6Q26770257-0B5E3400-8978-4753-B093-9DB73CD1748EQ26825666-FB1CF29A-8617-4D2F-A54E-8532F4624398Q26998296-913AA75D-AEDC-4A03-9202-04A6850A1A25Q27308853-E15FF76F-E785-4E6C-9E01-99E4C36F53DCQ27312222-723B4CB8-5199-465E-97DB-328B9A4643F4Q27314385-BF06FF09-B19F-4E89-B35A-9A96A50C2DF0Q27317293-1FB26DD4-9DA7-4609-926E-85A0AACDDABBQ28079126-79351019-5371-4A98-B8B2-B35CA093AB9CQ28085080-D517B80C-6249-4CB7-B72A-69F2AB51FF60Q28086831-54772EF9-957D-4D99-85D9-7CF5192282D0Q28478729-0767A509-CEB4-4C01-BA95-63E7E1EA204FQ28533202-8F62E66F-75DE-4336-A2C9-7F17758B6A32Q28543373-148E8636-E0DA-4E39-AC69-9FDD3D389650Q28575785-A03CEB94-F39D-4284-BF8D-73204251679EQ28586577-1940EC19-8705-4CD9-800A-E49DF7835067Q28658192-8723D7A5-50F5-4959-A1FE-0459073F4396Q28817694-0BF54E86-CE07-4182-9A34-CFE4EBA2EAA8Q29615500-077D04EE-D537-4BE1-B8BC-8431D16DC7CAQ30405378-E0BC4CC8-FB82-4576-A9D8-F8D01CB519AFQ30412824-6FAC9CE3-B6D1-4D1B-8438-021C640EAF6EQ30913978-A1CD4B7A-7F58-4D4D-B275-CB0B7F617062Q33620003-CDD4CEAD-A38B-4D73-8264-DFE46BA61634Q33636927-55EBCF0B-547A-43B4-9A5A-F6E071224DB2Q33652849-4C447923-4CE0-471F-A773-1398424EBD2BQ33692614-82C437F2-11F5-4E98-A32B-BC07F5070BCAQ33697768-7C5FB061-59F2-467D-A98B-1D71C4AA44E9Q33715004-1AE9DD0E-7907-4F2A-BA7C-72FBB6561D78Q33723160-F290270D-0F66-4592-B7D7-826B22684B1DQ33740585-B9291A40-70C6-4E12-87FE-3AB132F97009Q33755642-C59930E2-3E0A-49A0-904F-E11AE169272EQ33882444-88DF603E-2F7F-41DE-9B94-07EF51FAB939Q33894453-FF80DBE9-295E-49FB-AFE0-B0E80A62FA47Q33898213-5734A7D0-D516-4EF3-BF8F-412916B6F408
P2860
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Either a Th17 or a Th1 effecto ...... ct dominant effector category.
@ast
Either a Th17 or a Th1 effecto ...... ct dominant effector category.
@en
type
label
Either a Th17 or a Th1 effecto ...... ct dominant effector category.
@ast
Either a Th17 or a Th1 effecto ...... ct dominant effector category.
@en
prefLabel
Either a Th17 or a Th1 effecto ...... ct dominant effector category.
@ast
Either a Th17 or a Th1 effecto ...... ct dominant effector category.
@en
P2093
P2860
P50
P356
P1476
Either a Th17 or a Th1 effecto ...... ct dominant effector category.
@en
P2093
Daniel Cua
Dror Luger
Edward P Bowman
Nicole M Sgambellone
Phyllis B Silver
P2860
P304
P356
10.1084/JEM.20071258
P407
P577
2008-04-07T00:00:00Z